Skip to main content

Table 5 Distribution of AS on WBMRI compared with other imaging modalities

From: Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?

AS on WBMRI Compared to FDG-PET/CT Compared to CT or CT & BS
Bone only 3 13
Liver only 1 16
Bone and liver 0 4
Peritoneal/retroperitoneal 0 3
Liver and peritoneal 0 2
Nodes 1 1